Balancing Efficacy, Tolerability, and Drug Monitoring in Schizophrenia Treatment
Experts Dr. John Kane and Dr. Christoph Correll discuss the necessity of therapeutic drug monitoring and the balance between efficacy and tolerability in schizophrenia treatment. They argue for personalized treatment goals and the use of reliable delivery systems like injectables.
Why it matters
Improving the precision of psychiatric care can significantly reduce treatment resistance and improve the quality of life for patients with schizophrenia.
In "Balancing Efficacy, Tolerability, and Drug Monitoring in Schizophrenia Treatment," our panel explores two interconnected clinical priorities: the underutilization of therapeutic drug monitoring and the need to reframe how clinicians weigh efficacy against tolerability over the long term.
Clinical discussion focused on medical research and patient outcomes.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in